Article
Should genetic analysis in newborn screening and a heterozygote test for hyperphenylalaninaemia be recommended? An Italian study.
Journal of medical screening - 1 Jan 1999
Rottoli A, Gianní M L, Verduci E, Biondi M L, Fiori L, Giovannini M, Riva E
Abstract excerpt
OBJECTIVE: To determine whether the introduction of genetic analysis for phenylalanine hydroxylase (PAH) deficiency into regional screening programmes can be supported by the benefit-cost ratio. METHOD: Tests for the genetic PAH locus were carried out in 151 patients with hyperphenylalaninaemia originally from all of the Italian regions. PAH mutations were identified by extraction of genomic DNA from leucocytes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
